{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:31:58Z","timestamp":1786980718200,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Key Program for Clinical Research at Peking University Shenzhen Hospital","award":["LCYJZD2021007"],"award-info":[{"award-number":["LCYJZD2021007"]}]},{"name":"the Key Program for Clinical Research at Peking University Shenzhen Hospital","award":["LCYJZD2021007"],"award-info":[{"award-number":["LCYJZD2021007"]}]},{"name":"the Key Program for Clinical Research at Peking University Shenzhen Hospital","award":["LCYJZD2021007"],"award-info":[{"award-number":["LCYJZD2021007"]}]},{"name":"the Key Program for Clinical Research at Peking University Shenzhen Hospital","award":["LCYJZD2021007"],"award-info":[{"award-number":["LCYJZD2021007"]}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["JSGG20201102162802008"],"award-info":[{"award-number":["JSGG20201102162802008"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s10495-023-01908-3","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T13:02:10Z","timestamp":1701176530000},"page":"460-481","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Revealing the role of necroptosis microenvironment: FCGBP\u2009+\u2009tumor-associated macrophages drive primary liver cancer differentiation towards cHCC-CCA or iCCA"],"prefix":"10.1007","volume":"29","author":[{"given":"Chun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuimin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiakang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,28]]},"reference":[{"issue":"6","key":"1908_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality. CA Cancer J Clin 68(6):394\u2013424","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"1908_CR2","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nrc4017","volume":"15","author":"JU Marquardt","year":"2015","unstructured":"Marquardt JU, Andersen JB, Thorgeirsson SS (2015) Functional and genetic deconstruction of the cellular origin in liver cancer. Nat Rev Cancer 15(11):653\u2013667","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"1908_CR3","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.ccell.2019.04.007","volume":"35","author":"R Xue","year":"2019","unstructured":"Xue R, Chen LU, Zhang C et al (2019) Genomic and transcriptomic profiling of combined hepatocellular and intrahepatic cholangiocarcinoma reveals distinct molecular subtypes. Cancer Cell 35(6):932\u2013947","journal-title":"Cancer Cell"},{"issue":"3","key":"1908_CR4","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.jhep.2021.11.010","volume":"76","author":"Y Liu","year":"2022","unstructured":"Liu Y, Zhuo S, Zhou Y, Ma L et al (2022) Yap-Sox9 signaling determines hepatocyte plasticity and lineage-specific. J Hepatol 76(3):652\u2013664","journal-title":"J Hepatol"},{"issue":"8","key":"1908_CR5","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1172\/JCI63212","volume":"122","author":"B Fan","year":"2012","unstructured":"Fan B, Malato Y, Calvisi DF, Naqvi S et al (2012) Cholangiocarcinomas can originate from hepatocytes in mice. J Clin Invest 122(8):2911\u20132915","journal-title":"J Clin Invest"},{"issue":"11","key":"1908_CR6","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.1172\/JCI63065","volume":"122","author":"S Sekiya","year":"2012","unstructured":"Sekiya S, Suzuki A (2012) Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of. J Clin Invest 122(11):3914\u20133918","journal-title":"J Clin Invest"},{"issue":"4","key":"1908_CR7","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.jhep.2019.05.027","volume":"71","author":"J Wang","year":"2019","unstructured":"Wang J, Wang H, Peters M, Ding N et al (2019) Loss of Fbxw7 synergizes with activated Akt signaling to promote c-Myc dependent. J Hepatol 71(4):742\u2013752","journal-title":"J Hepatol"},{"issue":"16","key":"1908_CR8","doi-asserted-by":"publisher","first-page":"4445","DOI":"10.1158\/0008-5472.CAN-17-1123","volume":"78","author":"MA Hill","year":"2018","unstructured":"Hill MA, Alexander WB, Guo B et al (2018) Kras and Tp53 mutations cause cholangiocyte-and hepatocyte-derived cholangiocarcinoma. Cancer Res 78(16):4445\u20134451","journal-title":"Cancer Res"},{"issue":"1","key":"1908_CR9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/hep.29789","volume":"68","author":"E Brunt","year":"2018","unstructured":"Brunt E, Aishima S, Clavien PA, Fowler K et al (2018) cHCC-CCA: Consensus terminology for primary liver carcinomas with both. Hepatology 68(1):113\u2013126","journal-title":"Hepatology"},{"issue":"5","key":"1908_CR10","doi-asserted-by":"publisher","first-page":"7356","DOI":"10.1002\/jcp.27495","volume":"234","author":"Y Guo","year":"2019","unstructured":"Guo Y, Long J, Lei S (2019) Promoter methylation as biomarkers for diagnosis of melanoma: a systematic review and meta-analysis. J Cell Physiol 234(5):7356\u20137367","journal-title":"J Cell Physiol"},{"issue":"6","key":"1908_CR11","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1002\/hep.28508","volume":"63","author":"L Li","year":"2016","unstructured":"Li L, Che L, Tharp KM, Park HM et al (2016) Differential requirement for de novo lipogenesis in cholangiocarcinoma and. Hepatology 63(6):1900\u20131913","journal-title":"Hepatology"},{"issue":"47","key":"1908_CR12","doi-asserted-by":"publisher","first-page":"17059","DOI":"10.1073\/pnas.0502974102","volume":"102","author":"CM Carlson","year":"2005","unstructured":"Carlson CM, Frandsen JL, Kirchhof N, McIvor RS et al (2005) Somatic integration of an oncogene-harboring sleeping beauty transposon models. Proc Natl Acad Sci U S A 102(47):17059\u201317064","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"21","key":"1908_CR13","doi-asserted-by":"publisher","first-page":"8165","DOI":"10.3390\/ijms21218165","volume":"21","author":"Y Chang","year":"2020","unstructured":"Chang Y, Jeong SW, Young Jang J, Jae Kim Y (2020) Recent updates of transarterial chemoembolilzation in hepatocellular carcinoma. Int J Mol Sci 21(21):8165","journal-title":"Int J Mol Sci"},{"key":"1908_CR14","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803\u2013820","journal-title":"Acta Neuropathol"},{"issue":"2","key":"1908_CR15","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nchembio711","volume":"1","author":"A Degterev","year":"2005","unstructured":"Degterev A, Huang Z, Boyce M, Li Y et al (2005) Chemical inhibitor of nonapoptotic cell death with therapeutic potential for. Nat Chem Biol 1(2):112\u2013119","journal-title":"Nat Chem Biol"},{"issue":"8","key":"1908_CR16","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.3390\/cells9081823","volume":"9","author":"J Sprooten","year":"2020","unstructured":"Sprooten J, De Wijngaert P et al (2020) Necroptosis in immuno-oncology and cancer immunotherapy. Cells 9(8):1823","journal-title":"Cells"},{"issue":"1","key":"1908_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.trecan.2021.09.003","volume":"8","author":"J Yan","year":"2022","unstructured":"Yan J, Wan P, Choksi S, Liu ZG (2022) Necroptosis and tumor progression. Trends Cancer 8(1):21\u201327","journal-title":"Trends Cancer"},{"issue":"1","key":"1908_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-018-1235-0","volume":"15","author":"YK Dhuriya","year":"2018","unstructured":"Dhuriya YK, Sharma D (2018) Necroptosis: a regulated inflammatory mode of cell death. J Neuroinflammation 15(1):1\u20139","journal-title":"J Neuroinflammation"},{"issue":"1","key":"1908_CR19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.molcel.2014.03.003","volume":"54","author":"H Wang","year":"2014","unstructured":"Wang H, Sun L, Su L, Rizo J et al (2014) Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption. Mol Cell 54(1):133\u2013146","journal-title":"Mol Cell"},{"issue":"9","key":"1908_CR20","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1016\/j.celrep.2019.07.077","volume":"28","author":"SL Orozco","year":"2019","unstructured":"Orozco SL, Daniels BP, Yatim N, Messmer MN et al (2019) RIPK3 activation leads to cytokine synthesis that continues after loss of cell. Cell Rep 28(9):2275\u20132287","journal-title":"Cell Rep"},{"issue":"7725","key":"1908_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41586-018-0519-y","volume":"562","author":"M Seehawer","year":"2018","unstructured":"Seehawer M, Heinzmann F et al (2018) Necroptosis microenvironment directs lineage commitment in liver cancer. Nature 562(7725):69\u201375","journal-title":"Nature"},{"issue":"2","key":"1908_CR22","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.13975","volume":"76","author":"ID Nagtegaal","year":"2020","unstructured":"Nagtegaal ID, Odze RD, Klimstra D, Paradis V et al (2020) The 2019 WHO classification of tumours of the digestive system. Histopathology 76(2):182\u2013188","journal-title":"Histopathology"},{"issue":"1","key":"1908_CR23","doi-asserted-by":"publisher","first-page":"7533","DOI":"10.1038\/s41467-022-35291-5","volume":"13","author":"L Ma","year":"2022","unstructured":"Ma L, Heinrich S, Wang L et al (2022) Multiregional single-cell dissection of tumor and immune cells reveals stable lock-and-key features in liver cancer. Nat Commun 13(1):7533","journal-title":"Nat Commun"},{"issue":"6","key":"1908_CR24","doi-asserted-by":"publisher","first-page":"543","DOI":"10.21147\/j.issn.1000-9604.2022.06.01","volume":"34","author":"X Chu","year":"2022","unstructured":"Chu X, Zhang Y, Cheng S (2022) Heterogeneity of tumor-infiltrating myeloid cells in era of single-cell genomics. Chin J Cancer Res 34(6):543\u2013553","journal-title":"Chin J Cancer Res"},{"issue":"2","key":"1908_CR25","doi-asserted-by":"publisher","first-page":"102","DOI":"10.4132\/jptm.2020.10.22","volume":"55","author":"JW Park","year":"2021","unstructured":"Park JW, Kang J et al (2021) The prognostic significance of p16 expression pattern in diffuse gliomas. J Pathol Trans Med 55(2):102\u2013111","journal-title":"J Pathol Trans Med"},{"issue":"51","key":"1908_CR26","doi-asserted-by":"publisher","first-page":"eabg3750","DOI":"10.1126\/sciadv.abg3750","volume":"7","author":"R Wu","year":"2021","unstructured":"Wu R, Guo W, Qiu X et al (2021) Comprehensive analysis of spatial architecture in primary liver cancer. Sci Adv 7(51):eabg3750","journal-title":"Sci Adv"},{"issue":"4","key":"1908_CR27","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jhep.2023.01.011","volume":"78","author":"Y Liu","year":"2023","unstructured":"Liu Y, Xun Z, Ma K, Liang S et al (2023) Identification of a tumour immune barrier in the HCC microenvironment that. J Hepatol 78(4):770\u2013782","journal-title":"J Hepatol"},{"issue":"7","key":"1908_CR28","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","volume":"169","author":"A Ally","year":"2017","unstructured":"Ally A, Balasundaram M et al (2017) Comprehensive and integrative genomic characterization of hepatocellular carcinoma. Cell 169(7):1327\u20131341","journal-title":"Cell"},{"issue":"2\u20133","key":"1908_CR29","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ygeno.2014.01.003","volume":"103","author":"J Fernandez-Banet","year":"2014","unstructured":"Fernandez-Banet J, Lee NP, Chan KT, Gao H et al (2014) Decoding complex patterns of genomic rearrangement in hepatocellular carcinoma. Genomics 103(2\u20133):189\u2013203","journal-title":"Genomics"},{"issue":"3","key":"1908_CR30","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.stem.2019.12.011","volume":"26","author":"K Murata","year":"2020","unstructured":"Murata K, Jadhav U, Madha S, van Es J et al (2020) Ascl2-dependent cell dedifferentiation drives regeneration of ablated intestinal. Cell Stem Cell 26(3):377\u2013390","journal-title":"Cell Stem Cell"},{"issue":"1","key":"1908_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cpbi.5","volume":"54","author":"G Stelzer","year":"2016","unstructured":"Stelzer G, Rosen N, Plaschkes I, Zimmerman S et al (2016) The genecards suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinformatics 54(1):1\u20131","journal-title":"Curr Protoc Bioinformatics"},{"issue":"7848","key":"1908_CR32","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41586-021-03218-7","volume":"591","author":"N Kayagaki","year":"2021","unstructured":"Kayagaki N, Kornfeld OS et al (2021) NINJ1 mediates plasma membrane rupture during lytic cell death. Nature 591(7848):131\u2013136","journal-title":"Nature"},{"issue":"10","key":"1908_CR33","first-page":"023","volume":"17","author":"M Degen","year":"2023","unstructured":"Degen M, Orcid Id, Santos JC, Orcid Id et al (2023) Structural basis of NINJ1-mediated plasma membrane rupture in cell death. Nature 17(10):023\u201305991","journal-title":"Nature"},{"issue":"10","key":"1908_CR34","doi-asserted-by":"publisher","first-page":"6702","DOI":"10.1007\/s00330-022-09065-y","volume":"32","author":"C Zhou","year":"2022","unstructured":"Zhou C, Lu X, Wang Y, Qian X et al (2022) Histopathological components correlated with MRI features and prognosis in. Eur Radiol 32(10):6702\u20136711","journal-title":"Eur Radiol"},{"issue":"1","key":"1908_CR35","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2022.12.003","volume":"56","author":"X Zhang","year":"2023","unstructured":"Zhang X, Ji L, Li MO (2023) Control of tumor-associated macrophage responses by nutrient acquisition and metabolism. Immunity 56(1):14\u201331","journal-title":"Immunity"},{"issue":"1","key":"1908_CR36","doi-asserted-by":"publisher","first-page":"2085432","DOI":"10.1080\/2162402X.2022.2085432","volume":"11","author":"Z Liu","year":"2022","unstructured":"Liu Z, Gao Z, Li B, Li J et al (2022) Lipid-associated macrophages in the tumor-adipose microenvironment facilitate. Oncoimmunology 11(1):2085432","journal-title":"Oncoimmunology"},{"issue":"11","key":"1908_CR37","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1002\/cac2.12345","volume":"42","author":"K Cheng","year":"2022","unstructured":"Cheng K, Orcid Id, Cai N, Zhu J et al (2022) Tumor-associated macrophages in liver cancer: From mechanisms to therapy. Cancer Commun 42(11):1112\u20131140","journal-title":"Cancer Commun"},{"issue":"9","key":"1908_CR38","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1158\/0008-5472.CAN-17-2867","volume":"78","author":"YL Zhang","year":"2018","unstructured":"Zhang YL, Li Q, Yang XM, Fang F et al (2018) SPON2 promotes M1-like macrophage recruitment and inhibits hepatocellular. Cancer Res 78(9):2305\u20132317","journal-title":"Cancer Res"},{"key":"1908_CR39","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.3389\/fimmu.2019.01643","volume":"10","author":"Z Zong","year":"2019","unstructured":"Zong Z, Zou J, Mao R et al (2019) M1 macrophages induce PD-L1 expression in hepatocellular carcinoma cells through IL-1\u03b2 signaling. Front Immunol 10:1643","journal-title":"Front Immunol"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-023-01908-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-023-01908-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-023-01908-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T19:12:57Z","timestamp":1708369977000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-023-01908-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,28]]},"references-count":39,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["1908"],"URL":"https:\/\/doi.org\/10.1007\/s10495-023-01908-3","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,28]]},"assertion":[{"value":"17 October 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interst"}},{"value":"The samples used to perform the Immunofluorescence and immunohistochemistry were obtained from patients who gave informed consent and signed an informed consent form. The study was approved by the Ethical Review Committee of Peking University Shenzhen Hospital(PKUSZH)) (Approval Number: 2023115), and all experiments were performed inaccordance with the Declaration of Helsinki ethical guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declarethat they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}